Comparison of conventional prognostic indices in patients older than 60 years with diffuse large B-cell lymphoma treated with R-CHOP in the US Intergroup Study (ECOG 4494, CALGB 9793): consideration of age greater than 70 years in an elderly prognostic index (E-IPI).
      QxMD      Google Scholar   
Citation:
Br. J. Haematol. vol 151 (2) 143-51
Year:
2010
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
DataSharing:
No
Book Volume:
Parents:
None
Children:
None
Program:
CCP
Primary Committee:
Older Adult
Sec. Committees:
Health Outcome    
Pharmas:
 
Grants:
CA11083, CA13650, CA16450, CA21115, CA23318, CA32291, CA35431, CA66636, U10 CA011083, U10 CA013650, U10 CA021115, U10 CA023318, U10 CA032291, U10 CA035431, U10 CA066636, U24 CA114737  
Corr. Author:
 
Authors:
                   
Primary Study
C9793
Secondary Studies:
Phases:
3
Keywords:
Age Factors, Aged, Aged, 80 and over, Antibodies, Monoclonal, Murine-Derived, Antineoplastic Combined Chemotherapy Protocols, Cyclophosphamide, Doxorubicin, Drug Administration Schedule, Epidemiologic Methods, Health Status Indicators, Humans, Lymphoma, Large B-Cell, Diffuse, Middle Aged, Prednisone, Prognosis, Treatment Outcome, Vincristine